Skip to main content

Table 3 Patients with KFD with and without aseptic meningitis or encephalitis

From: Kikuchi-Fujimoto disease concurrent with aseptic meningitis or encephalitis in children: a case-control study

 

KFD With Aseptic Meningitis or Encephalitis (n = 16)

KFD Without Aseptic Meningitis or Encephalitis (n = 48)

P

Epidemiologic features

   

Age, yr

8.0(6.0-11.8)

10.0(7.0–12.0)

0.470

Male sex

11(68.8)

33(68.8)

1.000

Clinical features

   

Fever (≥ 39℃)

13(81.3)

39(81.3)

1.000

Cervical lymph node tenderness

15(93.8)

30(62.5)

0.032

Headache

11(68.8)

2(4.2)

0.000

Confusion

6(37.5)

0

0.000

Convulsions

5(31.3)

0

0.000

Cutaneous rash

6(37.5)

6(12.5)

0.064

Arthralgia

1(6.3)

0

0.250

Hepato-Splenomegaly

0

2(4.2)

1.000

Laboratory features

   

Leukopenia

14(87.5)

23(47.9)

0.062

Increased CRP

9(56.3)

8(16.7)

0.002

Increased ESR

14(87.5)

30(62.5)

0.062

Elevated liver enzymes

4(25.0)

15(31.3)

0.874

Treatment

   

Corticosteroids

11(68.8)

7(14.6)

0.000

IVIG

10(62.5)

2(4.2)

0.000

  1. Data are presented as n (%) or median (Q1–Q3)
  2. KFD, Kikuchi-Fujimoto disease; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; IVIG, intravenous immunoglobulin